{
  "id": 7475878,
  "title": "Amplia opens new front in ovarian cancer fight",
  "url": "https://urgent.news/2026/09/15/amplia-opens-new-front-in-ovarian-cancer-fight",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T04:53:36.000Z",
  "source": {
    "name": "The Sydney Morning Herald",
    "slug": "the-sydney-morning-herald",
    "url": "https://www.smh.com.au/business/companies/amplia-opens-new-front-in-ovarian-cancer-fight-20260915-p60xkn.html?ref=rss"
  },
  "original_language": "en",
  "account": null,
  "summary": "Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer trial, with site activation and patient recruitment targeted before year-end.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Age",
        "title": "Amplia opens new front in ovarian cancer fight",
        "url": "https://urgent.news/2026/09/15/amplia-opens-new-front-in-ovarian-cancer-fight-7476146",
        "published": "2026-09-15T04:53:36.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}